Vascular α1D-adrenoceptors are overexpressed in aorta of the aryl hydrocarbon receptor null mouse: Role of increased angiotensin II

Autonomic and Autacoid Pharmacology

Volumn 28, Issue 2-3, 2008, Pages 61-67

  Villalobos Molina, R ^a   Vazquez Cuevas F G ^a   Lopez Guerrero J J ^b   Figueroa Garcia M C ^a   Gallardo Ortiz, I A ^a   Ibarra, M ^a   Rodriguez Sosa M ^a   Gonzalez, F J ^c   Elizondo, G ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

1D adrenoceptors; Angiotensin II; Aryl hydrocarbon receptor null mouse; Captopril; Hypertension

Indexed keywords

8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1D ADRENERGIC RECEPTOR; ANGIOTENSIN II; AROMATIC HYDROCARBON RECEPTOR; CAPTOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG MECHANISM; GENE OVEREXPRESSION; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MOUSE; NONHUMAN; WESTERN BLOTTING;

ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; BLOTTING, WESTERN; CAPTOPRIL; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOREPINEPHRINE; PHENYLEPHRINE; PIPERAZINES; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASOCONSTRICTION;

EID: 47249085540     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2008.00418.x     Document Type: Article

References (25)

1. ARUNLAKSHANA, O. SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48 58.
2. FERRARIO, C., ABDELHAMED, A.I. MOORE, M. (2004). Angiotensin II antagonists in hypertension, heart failure, and diabetic nephropathy: focus on losartan. Curr. Med. Res. Opin., 20, 279 293.
3. 1D-adrenergic receptor: molecular and cellular characteristics and integrative roles. Eur. J. Pharmacol., 500, 113 120.
4. 1D-adrenergic receptors. Biochem. J., 353, 603 610.
5. 1D-adrenoceptors in arteries of spontaneously hypertensive rats. Br. J. Pharmacol., 135, 206 216.
6. 1D-adrenoceptors in aorta of pre-hypertensive rats. Auton. Autacoid. Pharmacol., 26, 21 29.
7. GONZALES, F.J. FERNANDEZ-SALGUERO, P. (1998). The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab. Disp., 26, 1194 1198.
8. GUIMARAES, S. MOURA, D. (2001). Vascular adrenoceptors: an update. Pharmacol. Rev., 53, 319 356.
9. HENRICH, W.L. LEVI, M. (1991). Ontogeny of renal rennin release in spontaneously hypertensive rat and Wistar-Kyoto rat. Am. J. Physiol., 260, F530 F535.
10. HU, Z.W., SHI, X.Y., OKAZAKI, M. HOFFMAN, B.B. (1995). Angiotensin II induces transcription and expression of alpha-1 adrenergic receptors in vascular smooth muscle cells. Am. J. Physiol., 268, H1006 H1014.
11. HUNYADY, L. CATT, K.J. (2006). Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol., 20, 953 970.
12. 1D-adrenoceptor knockout mice. Auton. Autacoid. Pharmacol., 25, 179 183.
13. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265 275.
14. LUND, A.K., GOENS, M.B., KANAGY, N.L. WALKER, M.K. (2003). Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1 and mean arterial blood pressure. Toxicol. Appl. Pharmacol., 193, 177 187.
15. MARTÍNEZ, A.L. VILLALOBOS-MOLINA, R. (2003). Early and chronic captopril or losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats. Arch. Med. Res., 34, 357 361.
16. RUIZ, P., BASSO, N., CANNATA, M.A. TAQUINI, A.C. (1990). The renin-angiotensin system in different stages of spontaneous hypertension in the rat (SHR). Clin. Exp. Hypertens. A, 12, 63 81.
17. 1D- adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J. Clin. Invest., 109, 765 775.
18. 1A subtypes. Eur. J. Pharmacol., 298, 257 263.
19. 1D- adrenoceptors: are they related to hypertension? Arch. Med. Res., 30, 347 352.
20. 1D-adrenoceptors may mediate the pro-hypertensive effects of angiotensin II. Mol. Interv., 5, 340 342.
21. 1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats. Br. J. Pharmacol., 126, 1534 1536.
22. WEIR, M.R. DZAU, V.J. (1999). The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am. J. Hypertens., 12, 205S 213S.
23. 1D-Adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol. Pharmacol., 51, 764 775.
24. YAMAMOTO, Y. KOIKE, K. (2001). Characterization of alpha1-adrenoceptor- mediated contraction in the mouse thoracic aorta. Eur. J. Pharmacol., 424, 131 140.
25. ZICHA, J. KUNE, J. (1999). Ontogenetic aspects of hypertension development: analysis in the rat. Physiol. Rev., 79, 1227 1282.